Direkt zum Inhalt
Merck
  • Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.

Cardiogenic shock triggered by verapamil and atenolol: a case report of therapeutic experience with intravenous calcium.

Japanese circulation journal (2000-12-08)
H Sakurai, M Kei, K Matsubara, K Yokouchi, K Hattori, R Ichihashi, Y Hirakawa, H Tsukamoto, Y Saburi
ZUSAMMENFASSUNG

Cardiogenic shock developed in a 72-year-old Japanese woman during combination therapy with verapamil and atenolol for recurrent supraventricular arrhythmia. She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome. Despite of the high-dose catecholamines and counterpulsation, she progressively deteriorated. Bolus administration of intravenous calcium chloride (CaCl2) immediately resolved her hemodynamic collapse.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Atenolol, ≥98% (TLC), powder
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Supelco
Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant®
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
USP
Atenolol, United States Pharmacopeia (USP) Reference Standard
Preise und Verfügbarkeit sind derzeit nicht verfügbar.
Atenolol, European Pharmacopoeia (EP) Reference Standard
Preise und Verfügbarkeit sind derzeit nicht verfügbar.